319 related articles for article (PubMed ID: 26134396)
21. Parkinson's disease-associated human P5B-ATPase ATP13A2 increases spermidine uptake.
De La Hera DP; Corradi GR; Adamo HP; De Tezanos Pinto F
Biochem J; 2013 Feb; 450(1):47-53. PubMed ID: 23205587
[TBL] [Abstract][Full Text] [Related]
22. Regulation of intracellular manganese homeostasis by Kufor-Rakeb syndrome-associated ATP13A2 protein.
Tan J; Zhang T; Jiang L; Chi J; Hu D; Pan Q; Wang D; Zhang Z
J Biol Chem; 2011 Aug; 286(34):29654-62. PubMed ID: 21724849
[TBL] [Abstract][Full Text] [Related]
23. Impulse control disorder, lysosomal malfunction and ATP13A2 insufficiency in Parkinsonism.
Liu JP; Li J; Lu Y; Wang L; Chen G
Clin Exp Pharmacol Physiol; 2017 Feb; 44(2):172-179. PubMed ID: 27997702
[TBL] [Abstract][Full Text] [Related]
24. Pathogenic effects of novel mutations in the P-type ATPase ATP13A2 (PARK9) causing Kufor-Rakeb syndrome, a form of early-onset parkinsonism.
Park JS; Mehta P; Cooper AA; Veivers D; Heimbach A; Stiller B; Kubisch C; Fung VS; Krainc D; Mackay-Sim A; Sue CM
Hum Mutat; 2011 Aug; 32(8):956-64. PubMed ID: 21542062
[TBL] [Abstract][Full Text] [Related]
25. Dysregulated iron metabolism in C. elegans catp-6/ATP13A2 mutant impairs mitochondrial function.
Anand N; Holcom A; Broussalian M; Schmidt M; Chinta SJ; Lithgow GJ; Andersen JK; Chamoli M
Neurobiol Dis; 2020 Jun; 139():104786. PubMed ID: 32032734
[TBL] [Abstract][Full Text] [Related]
26. α-Synuclein-independent histopathological and motor deficits in mice lacking the endolysosomal Parkinsonism protein Atp13a2.
Kett LR; Stiller B; Bernath MM; Tasset I; Blesa J; Jackson-Lewis V; Chan RB; Zhou B; Di Paolo G; Przedborski S; Cuervo AM; Dauer WT
J Neurosci; 2015 Apr; 35(14):5724-42. PubMed ID: 25855184
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of human Atp13a2Isoform-1 protein protects cells against manganese and starvation-induced toxicity.
Ugolino J; Dziki KM; Kim A; Wu JJ; Vogel BE; Monteiro MJ
PLoS One; 2019; 14(8):e0220849. PubMed ID: 31393918
[TBL] [Abstract][Full Text] [Related]
28. A familial ATP13A2 mutation enhances alpha-synuclein aggregation and promotes cell death.
Lopes da Fonseca T; Pinho R; Outeiro TF
Hum Mol Genet; 2016 Jul; 25(14):2959-2971. PubMed ID: 27282395
[TBL] [Abstract][Full Text] [Related]
29. The zebrafish homologue of Parkinson's disease ATP13A2 is essential for embryonic survival.
Lopes da Fonseca T; Correia A; Hasselaar W; van der Linde HC; Willemsen R; Outeiro TF
Brain Res Bull; 2013 Jan; 90():118-26. PubMed ID: 23123961
[TBL] [Abstract][Full Text] [Related]
30. The effect of manganese exposure in Atp13a2-deficient mice.
Fleming SM; Santiago NA; Mullin EJ; Pamphile S; Karkare S; Lemkuhl A; Ekhator OR; Linn SC; Holden JG; Aga DS; Roth JA; Liou B; Sun Y; Shull GE; Schultheis PJ
Neurotoxicology; 2018 Jan; 64():256-266. PubMed ID: 28595912
[TBL] [Abstract][Full Text] [Related]
31. Loss of ATP13A2 impairs glycolytic function in Kufor-Rakeb syndrome patient-derived cell models.
Park JS; Koentjoro B; Davis RL; Sue CM
Parkinsonism Relat Disord; 2016 Jun; 27():67-73. PubMed ID: 27039055
[TBL] [Abstract][Full Text] [Related]
32. Cryo-EM reveals mechanistic insights into lipid-facilitated polyamine export by human ATP13A2.
Tomita A; Daiho T; Kusakizako T; Yamashita K; Ogasawara S; Murata T; Nishizawa T; Nureki O
Mol Cell; 2021 Dec; 81(23):4799-4809.e5. PubMed ID: 34798056
[TBL] [Abstract][Full Text] [Related]
33. Mutations in the ATP13A2 gene and Parkinsonism: a preliminary review.
Yang X; Xu Y
Biomed Res Int; 2014; 2014():371256. PubMed ID: 25197640
[TBL] [Abstract][Full Text] [Related]
34. Lysosomal dysfunction in Parkinson disease: ATP13A2 gets into the groove.
Dehay B; Martinez-Vicente M; Ramirez A; Perier C; Klein C; Vila M; Bezard E
Autophagy; 2012 Sep; 8(9):1389-91. PubMed ID: 22885599
[TBL] [Abstract][Full Text] [Related]
35. Structural basis of polyamine transport by human ATP13A2 (PARK9).
Sim SI; von Bülow S; Hummer G; Park E
Mol Cell; 2021 Nov; 81(22):4635-4649.e8. PubMed ID: 34715013
[TBL] [Abstract][Full Text] [Related]
36. Identification of novel ATP13A2 interactors and their role in α-synuclein misfolding and toxicity.
Usenovic M; Knight AL; Ray A; Wong V; Brown KR; Caldwell GA; Caldwell KA; Stagljar I; Krainc D
Hum Mol Genet; 2012 Sep; 21(17):3785-94. PubMed ID: 22645275
[TBL] [Abstract][Full Text] [Related]
37. Structural mechanisms for gating and ion selectivity of the human polyamine transporter ATP13A2.
Tillinghast J; Drury S; Bowser D; Benn A; Lee KPK
Mol Cell; 2021 Nov; 81(22):4650-4662.e4. PubMed ID: 34715014
[TBL] [Abstract][Full Text] [Related]
38. Common pathogenic effects of missense mutations in the P-type ATPase ATP13A2 (PARK9) associated with early-onset parkinsonism.
Podhajska A; Musso A; Trancikova A; Stafa K; Moser R; Sonnay S; Glauser L; Moore DJ
PLoS One; 2012; 7(6):e39942. PubMed ID: 22768177
[TBL] [Abstract][Full Text] [Related]
39. ATP13A2 modifies mitochondrial localization of overexpressed TOM20 to autolysosomal pathway.
Hatori Y; Kanda Y; Nonaka S; Nakanishi H; Kitazawa T
PLoS One; 2022; 17(11):e0276823. PubMed ID: 36445873
[TBL] [Abstract][Full Text] [Related]
40. Parkinson's disease-associated human ATP13A2 (PARK9) deficiency causes zinc dyshomeostasis and mitochondrial dysfunction.
Park JS; Koentjoro B; Veivers D; Mackay-Sim A; Sue CM
Hum Mol Genet; 2014 Jun; 23(11):2802-15. PubMed ID: 24399444
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
